Junchun Chen
Impact in
- Analytical Chemistry top 10%
- Analytical Methods in Pharmaceuticals
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Bone Metabolism and Diseases 11
- Phosphodiesterase function and regulation 6
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Jianzhong Shentu (11 shared papers)Huili Zhou (8 shared papers)Mingzhu Huang (6 shared papers)Ji‐Qiang Chen (4 shared papers)Lihua Wu (8 shared papers)Jiake Xu (13 shared papers)Yuangang Su (11 shared papers)Jinmin Zhao (10 shared papers)
In The Last Decade
Junchun Chen
32 papers receiving 320 citations
Peers
Comparison fields: 5 of 90
- Analytical Chemistry 56
- Internal Medicine 17
- Pharmaceutical Science 19
- Pharmacology 27
- Pharmacology 50
Countries citing papers authored by Junchun Chen
This map shows the geographic impact of Junchun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junchun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junchun Chen more than expected).
Fields of papers citing papers by Junchun Chen
This network shows the impact of papers produced by Junchun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junchun Chen. The network helps show where Junchun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Junchun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 31 | |
| 2 | 2023 | 30 | |
| 3 | 2005 | 28 | |
| 4 | 2008 | 28 | |
| 5 | 2009 | 23 | |
| 6 | 2012 | 20 | |
| 7 | 2023 | 19 | |
| 8 | 2023 | 14 | |
| 9 | 2019 | 13 | |
| 10 | 2022 | 12 | |
| 11 | 2024 | 10 | |
| 12 | 2009 | 10 | |
| 13 | 2017 | 9 | |
| 14 | Inhibition of human phosphodiesterase 4A expressed in yeast cell GL62 by theophylline, rolipram, and acetamide-45. | 2002 | 9 |
| 15 | 2012 | 7 | |
| 16 | 2024 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 6 | |
| 19 | Selective inhibition of purified human phosphodiesterase 4A expressed in yeast cell GL62 by ciclamilast, piclamilast, and rolipram. | 2004 | 6 |
| 20 | 2005 | 5 |
About Junchun Chen
Junchun Chen is a scholar working on Molecular Biology, Pharmacology, Oncology, Cancer Research and Physiology, having authored 32 papers that have together received 331 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (11 papers), Bone health and treatments (6 papers), Phosphodiesterase function and regulation (6 papers), NF-κB Signaling Pathways (5 papers), Mast cells and histamine (3 papers), Analytical Methods in Pharmaceuticals (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Analytical Chemistry (56 citations), Internal Medicine (17 citations), Pharmaceutical Science (19 citations), Pharmacology (27 citations) and Pharmacology (50 citations). Junchun Chen has collaborated with scholars based in China, Australia and Hong Kong. Frequent co-authors include Jianzhong Shentu, Huili Zhou, Mingzhu Huang, Ji‐Qiang Chen, Lihua Wu, Jiake Xu, Yuangang Su, Jinmin Zhao, Huifang Tang and Xingjiang Hu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Journal of Zhejiang University SCIENCE B, Acta Pharmacologica Sinica, Clinical Therapeutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.